Explore more publications!
Health Wire Taiwan
Got News to Share?

Press Releases

Micro Injection Molded Plastic Market to Reach US$2.8B by 2031 at 11.2% CAGR | Driving Medical & Electronics Innovation
Feb. 20, 2026

Micro Injection Molded Plastic Market to Reach US$2.8B by 2031 at 11.2% CAGR | Driving Medical & Electronics Innovation

Neutral EIN Presswire
Medical Injection Molding Company in ISO 13485 Cleanrooms in Taiwan | THY Precision
Feb. 16, 2026

Medical Injection Molding Company in ISO 13485 Cleanrooms in Taiwan | THY Precision

Neutral EIN Presswire
Why Corporate Wellness Is a Must-Invest Market Now: USD 138.37 Bn Growth Reshaping Workplace Health
Feb. 17, 2026

Why Corporate Wellness Is a Must-Invest Market Now: USD 138.37 Bn Growth Reshaping Workplace Health

Indeterminate GlobeNewswire, Inc.
Drug Reference Apps Market to Reach USD 3.55 Billion by 2035, Driven by Digital Healthcare Adoption and North America’s Technological Leadership
Feb. 16, 2026

Drug Reference Apps Market to Reach USD 3.55 Billion by 2035, Driven by Digital Healthcare Adoption and North America’s Technological Leadership

Indeterminate GlobeNewswire, Inc.
Taiwan’s New Strategic Investment Instrument to Announce First-Round Selections Before Lunar New Year
Feb. 13, 2026

Taiwan’s New Strategic Investment Instrument to Announce First-Round Selections Before Lunar New Year

Indeterminate GlobeNewswire, Inc.
Medical Power Supply Market Overview, Trends & Forecast to 2034 with Key Industry Developments
Feb. 11, 2026

Medical Power Supply Market Overview, Trends & Forecast to 2034 with Key Industry Developments

Neutral EIN Presswire
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
Feb. 13, 2026

Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery

Indeterminate GlobeNewswire, Inc.
Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025
Feb. 13, 2026

Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025

Indeterminate GlobeNewswire, Inc.
Daeshin MC’s ‘Solecheck’ Designated as an Excellent Procurement Product
7 hours ago

Daeshin MC’s ‘Solecheck’ Designated as an Excellent Procurement Product

Neutral EIN Presswire
Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia
Feb. 12, 2026

Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia

Indeterminate GlobeNewswire, Inc.
ANEUVO Recognized with Taiwan’s 22nd National Innovation Award for ExaStim® Neuromodulation Technology
Feb. 11, 2026

ANEUVO Recognized with Taiwan’s 22nd National Innovation Award for ExaStim® Neuromodulation Technology

Indeterminate GlobeNewswire, Inc.
RNA Analysis Market Size Worth USD 23.39 Billion by 2035 Fueled by Expansion of RNA Therapeutics and Precision Medicine
Feb. 11, 2026

RNA Analysis Market Size Worth USD 23.39 Billion by 2035 Fueled by Expansion of RNA Therapeutics and Precision Medicine

Indeterminate GlobeNewswire, Inc.
Single-Use Disposable Medical Devices Market Size to Reach USD 310.92 Billion by 2035 Driven by Chronic Disease Burden and Home Healthcare Demand
Feb. 10, 2026

Single-Use Disposable Medical Devices Market Size to Reach USD 310.92 Billion by 2035 Driven by Chronic Disease Burden and Home Healthcare Demand

Indeterminate GlobeNewswire, Inc.
Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China
Feb. 9, 2026

Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China

Indeterminate GlobeNewswire, Inc.
Advanced Coating for Healthcare Packaging Market Trends 2026-2035
Feb. 6, 2026

Advanced Coating for Healthcare Packaging Market Trends 2026-2035

Indeterminate GlobeNewswire, Inc.
Generic Drugs Market Size to Reach USD 762.48 Billion by 2035 Driven by Rising Chronic Disease Burden and Cost-Control Focus
Feb. 6, 2026

Generic Drugs Market Size to Reach USD 762.48 Billion by 2035 Driven by Rising Chronic Disease Burden and Cost-Control Focus

Indeterminate GlobeNewswire, Inc.
Top Operating Lamp Manufacturers Driving Innovation in Medical Equipment
Feb. 6, 2026

Top Operating Lamp Manufacturers Driving Innovation in Medical Equipment

Neutral EIN Presswire
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
Feb. 5, 2026

Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®

Indeterminate GlobeNewswire, Inc.
Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026
Feb. 3, 2026

Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026

Indeterminate GlobeNewswire, Inc.
Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease
Feb. 2, 2026

Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions